INFORMATION SESSION — Introducing CADTH’s New Post-Market Drug Evaluation Program

Event Date: Tuesday, February 8, 2022
Time: 1:15pm to 2:00pm. EST
Zoom Webinar (Free — Registration Required)

The new CADTH Post-Market Drug Evaluation (PMDE) Program will be launching a reimagined evidence generation network in September 2022. The program will bring together an external network of Canada’s expert applied researchers, methodologists, and data analysts to provide evidence to answer the policy questions posed by federal, provincial, and territorial decision-makers as they pertain to post-market drug safety and effectiveness. Members from the PMDE Operations Centre will host a 45-minute information session to provide attendees with an overview of the program, share insight on who should apply to the upcoming Request for Proposals and how, and to answer questions.

Moderated by:

  • Heather Logan (Executive Strategy Lead)


  • Dr. Tarry Ahuja, PhD (Director, PMDE)
  • Nadine Sulatycky, MASc (PMDE Program Lead)


  • Provide attendees with an overview of the new CADTH PMDE program and its pan-Canadian query response network
  • Share guidance on how to respond to the Request for Proposals (RFP) for grant funding
  • Answer attendee questions through a forum — Submit your questions to a live panel

To participate, please register (there is no cost). After registering, you will receive a confirmation email with information about how to join the webinar.

Register now: